Testimonials

Their Words, Not Ours

I was really impressed with the congress organization and the audience who represented top biosimilars experts worldwide. I believe the event offered an excellent platform for sharing insights and points of views of the different stake holders from both the industry and the regulators’ sides. Would certainly want to participate next year.

Dr Mourad Farouk

Medical Director @ International Development

Thank you for a good experience with the PARADIGM Global Events…
very high level, very good Organization, we overpassed our expectatives, we will be pending for another congress related to pharmaceutical and biotech… we learned a lot, and i think that the content of agenda was state of the art, thank you again.

Salvador Berrios

ERP/ CRM / Product Configurator Manager

It was a pleasure presenting at this year’s conference and thank you very much for the excellent organization.

Robert Friesen

VP and Head, Biologics Research @ Janssen

Many thanks for your support at the Congress last week, I found the meeting extremely informative and the Paradigm team absolutely fantastic!

Costantino Congiatu

PhD, Senior Specialist, Regulatory Affairs

PGE organizes an International, high quality conference packed with highly relevant presentations by EMA biosimilar assessors, biosimilar developers and originators with a high degree of delegate interaction.

Richard Di Cicco

CEO @ Harvest Moon

Great conference, varied and very relevant material. Great speakers and organizers. Was worth attending. Looking forward to next year’s event

Dr. Hanane Cherif

Quality and Compliance Director

A very interesting conference. Comprehensive programme. Highly qualified speakers

Dr. David Uguen

Exec. Director, Voisin Consulting Life Sciences

Very useful knowledge exchange

Marcus Mreyen

Director @ Protagen Protein Services

Fantastic speakers, very informative event

Agnieszka Kulesca

Clinical Operations Manager @ Biovirtus Research Site

Very informative Conference.

Dr. Adrian Haines

Senior Principal senior Scientist @ Lonza Biologics

Great interactive discussion with experts in their field.

Dr. Fiona Greer

Global Director, SGS M-SCAN

The 2014 Biosimilars Global Congress stimulated collaborative discussion to facilitate advancing the science and medicine for biosimilar product access for patients

Dr. Nancy Martin

VP, Clinical Development, Hospira

The program is very informative, far more comprehensive than others of this type

Renita Rathinam

Lawyer, Sughrue Mion PLLC, Litigation

The event provided a lot of different point of views about the same topic (Biosimilars)

Gabriela Scarpa

Product Manager, Marketing, Janssen

Well moderated event, interesting presentations, comfortable location

Dr. Roberta Marcone

Analytical Development and GMP Section Manager, Patheon

Conference had topics stimulating the interest of everyone from the biosimilars novices to the experts – overall great conference

Priyanku Basu

Senior Analyst, BCG

Paradigm organizes a packed high quality agenda with high quality industry and EMA assessor speakers

Richard DiCicco

Chairman, Harvest Moon Pharmaceuticals USA

I was impressed with the organization of this event. I attend many conferences per year and find the organizers on site to be detached and not focus on good service to the delegates. This team was even providing weather forecast warning to ensure everyone was aware and made appropriate plans. Well Done.

Adriana E. Manzi

PhD, Managing Director, Atheln, Inc

The consistently high quality of international faculty was most impressive. It was also obvious that they were carefully chosen not only for their particular expertise but also for their ability to communicate the subject matter to clinical and non-clinical participants alike. As market access consultant for pharma clients of various sizes, I now feel much better prepared to explain the nuances & dynamics involved in bringing their products to market. In addition, I am in a much better position to intelligently advice my clients & help them set realistic expectations

Thomas Martin

Associate Vice President, VCGA - Quintiles

Very Interesting conference, with a 360 approach to a relatively new topic. The high level of the speakers ensured the robustness of the event. I’d like to attend again next year. Thank you!

Dr. Eva Agostina Montouri

Medical Affairs, Pfizer

The 2014 Biosimilars Global Congress stimulated collaborative discussion to facilitate advancing the science and medicine for biosimilar product access for patients.

Dr. Nancy Martin

VP, Clinical Development, Hospira

This event is really what you need in terms of content, information, speakers. Happy to be here. I feel well informed and updated. Great, well organized and interesting. Looking forward to the next one.

Naoul Zouaghi

Marketing Director, Mabxience

Great interactive discussion with experts in their field.

Dr. Fiona Greer

Global Director, SGS

As a relatively new supplier to the Biosimilar market, this event provided essential background & market specifics data. Looking forward to the next one

David Sadler

President, Zotek King Lai Co. Ltd

Conference had topics stimulating the interest of everyone from the biosimilars novices to the experts – overall great conference!

Priyanku Basu

Senior Analyst, BCG

Well balanced, Informative, Good size for networking

D. Andrew Simpson

CSO, ORYGEN

Biosimilars Global Congress 2015 was a conference of first time presentations.

Richard DiCicco

Chairman, HarvestMoon Pharma

The event provided a lot of different point of views about the same topic (Biosimilars).

Gabriela Scarpa

Marketing, Janssen

Great Conference! Excellent exchange of very relevant information. I will definitely plan on attending other PGE conferences in the future. Thank you.

Carla Goetz

Hospira

It is very informative to get a such comprehensive update for the different aspects in the fi eld of Biosimilars, which is a fast developing field.

Marcus Myeren

Protagen

The conference was extremely informative and valuable especially for an earlier stage company.

Darryl Sampey

BioFactura, Inc.

The 2015 Biosimilars and Follow-on Biologics USA PGE event was monumental because I learned that EMA might accept phase III trials performed in India for a Biosimilar application in Europe. Also. I learned that Biosimilar discounts are now 50-70% for mAbs in Europe. One cannot learn this information elsewhere.

Rich DiCicco

Harvest Moon Pharmaceuticals

Very interesting event and program. Very useful and comprehensive material delivered. Good speakers. Congratulations.

Graciela Aguilar

Qually Corporacion, SA de CV

This Conference was perfect in every way. Great presentations, les-sons learned, information provided and organization. Looking forward to the next one.

Raquel Smaletz Tcherniakovvsky

Libbs Farmaceutica

Great conference to understand what is going on internationally in the Biosimilar game.

Faridah Saadat

Wyatt Health Management

This event is a can’t miss!! Learnings about the latest on Biosimilars plus the opportunities to network with the experts in this fi eld are in-valuable. You’ll learn multi region perspective and gain a 360 degree view on how to develop and commercialize Biosimilars.

Rick Satitpunwaycha

Spectrum Pharmaceuticals

The event was great at understanding different perspective of all the stakeholders.

Mohit Bansal

Deutsche Bank

It was a great conference, great speakers, great interactive conference and well moderated event.

Roberto Tena Alavez

Grupo Somar

It was very informative conference in the Biosimilar field.

Weon Kyoo You

Hanwha Chemicals

I get to see the evolution of the market by attending year after year. Unmissable.

Liz Fuller

Bird & Bird